Therapeutic Asset Ratings
195 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Zimberelimab
Advanced Pancreatic Cancer
Jonsson Comprehensive Cancer Center
P2
B
(58)
Anhydrous Enol-Oxaloacetate
Anatomic Stage 0 Breast Cancer AJCC v8
Jonsson Comprehensive Cancer Center
P2
B
(57)
Anhydrous Enol-Oxaloacetate
Anatomic Stage IA Breast Cancer AJCC v8
Jonsson Comprehensive Cancer Center
P2
B
(57)
Anhydrous Enol-Oxaloacetate
Anatomic Stage I Breast Cancer AJCC v8
Jonsson Comprehensive Cancer Center
P2
B
(57)
Arimidex
Recurrent Fallopian Tube Carcinoma
Jonsson Comprehensive Cancer Center
P2
B
(57)
Durvalumab
Cholangiocarcinoma
Jonsson Comprehensive Cancer Center
P2
B
(57)
Cyclophosphamide
CD19 Positive
Jonsson Comprehensive Cancer Center
P1/2
B
(57)
Fludarabine
CD19 Positive
Jonsson Comprehensive Cancer Center
P1/2
B
(57)
Venetoclax
CTCL
Jonsson Comprehensive Cancer Center
P1/2
B
(57)
Zirconium Zr 89 girentuximab deferoxamine
Renal Cell Carcinoma
Jonsson Comprehensive Cancer Center
P2/3
B
(57)
ABT-700-VCMMAE
Non Small Cell Lung Cancer
Jonsson Comprehensive Cancer Center
P3
B
(56)
lutetium (<sup>177</sup>Lu) zadavotide guraxetan
Metastatic Castration-Resistant Prostate Cancer
Jonsson Comprehensive Cancer Center
P3
B
(56)
FLUDEOXYGLUCOSE
Glioblastoma
Jonsson Comprehensive Cancer Center
P2
CCC
(55)
Zimberelimab
Cholangiocarcinoma
Jonsson Comprehensive Cancer Center
P2
CCC
(55)
Evomela
Solid Tumor
Jonsson Comprehensive Cancer Center
P1/2
CCC
(55)
Tocilizumab
Primary Mediastinal B-cell Lymphoma (PMBCL)
Jonsson Comprehensive Cancer Center
P1/2
CCC
(55)
Zimberelimab
Adenocarcinoma of the Pancreas
Jonsson Comprehensive Cancer Center
P1/2
CCC
(54)
Abemaciclib
Recurrent Fallopian Tube Carcinoma
Jonsson Comprehensive Cancer Center
P2
CCC
(53)
Arimidex
Recurrent Primary Peritoneal Carcinoma
Jonsson Comprehensive Cancer Center
P2
CCC
(53)
gsk1120212
Hormone-Resistant Prostate Cancer
Jonsson Comprehensive Cancer Center
P2
CCC
(53)
gsk1120212
Metastatic Prostate Carcinoma
Jonsson Comprehensive Cancer Center
P2
CCC
(53)
gsk1120212
Prostate Carcinoma
Jonsson Comprehensive Cancer Center
P2
CCC
(53)
gsk1120212
Recurrent Prostate Carcinoma
Jonsson Comprehensive Cancer Center
P2
CCC
(53)
Imlunestrant
Invasive Breast Carcinoma
Jonsson Comprehensive Cancer Center
P2
CCC
(53)
Imlunestrant
Localized Estrogen Receptor-Positive Breast Carcinoma
Jonsson Comprehensive Cancer Center
P2
CCC
(53)
Showing 51 to 75 of 195 assets
Previous
Page 3 of 8
Next
